Kalkine has a fully transformed New Avatar.
Macquarie Atlas Roads Group
Macquarie Atlas Roads Group (ASX: MQA), a global toll road developer with interests in five major international toll roads, had last updated the market about Macquarie Group Limited (Macquarie) completing the sale of its 11.3% principal holding in MQA. Macquarie had sold 76 million securities in MQA at a price of $6.00 per security to a wide range of institutional investors through a bookbuild. Meanwhile, MQA stock has risen 15.60% in three months as on January 08, 2018 and is trading at a low P/E.
While MQA would now like to have majority of interests embedded internally only, the media recently reported that Macquarie Atlas might bear the consequences of recent US tax changes. Particularly, the group may be required to start paying tax on its Dulles Greenway toll-road (100% interests) near Washington DC for a period of time at the back of changes to interest deduction. The changes in corporate tax payments are said to entail net interest deduction at 30% of earnings before interest, taxation and depreciation and amortisation (EBITDA) until 2021, and to 30% of earnings before interest and taxes (EBIT) thereafter. The Dulles Greenway toll-road was not subject to taxes for MQA and the taxable income or loss has been generally recognised by its partners until now.
On the other hand, changes to French taxation system entailing the lessening of the corporate income tax rate to 25% by 2022, are signalled to positively impact the group owing to its stake in French toll-road Autoroutes Paris-Rhin-Rhone (APRR). Thus, earnings from APRR are expected to boost performance in long-term.
The stock that is up 28.5% in last one year (as at January 08, 2018) is at high level and it would be better to “Hold” at the current price of $6.23
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.